Year: 2019

Loughborough, England, Dec. 05, 2019 (GLOBE NEWSWIRE) —  Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for diabetics and pre-diabetics, announced that it has expanded its SugarBEAT® CGM capabilities by launching a new digital health offering, BEAT® Diabetes (www.BEATdiabetes.life), which focuses on the prevention and reversal of Type II diabetes through a range of holistic app and coaching services encouraging behavioural change. Both BEAT® Diabetes and SugarBEAT® target the underserved $69 billion market for Type 2 diabetics and $50 billion market for pre-diabetics.   Combining apps and coaching for patients has been independently and clinically proven to enhance the impact of...

MIAMI, Dec. 05, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), The Prostate Cancer Company, an oncology and urology biopharmaceutical company developing novel medicines for the management of prostate cancer, today announced that it will report financial results for its fiscal 2019 fourth quarter and full year ended September 30, 2019 on Thursday, December 12, 2019, before the market opens.  Veru’s management will host a conference call that same day at 8 a.m. Eastern Time to review the Company’s performance and answer questions.Event DetailsInterested investors may access the call by dialing 800-341-1602 from the U.S. or 412-902-6706 from outside the U.S. and asking to be joined into the Veru Inc. call.In addition, investors may access a replay of the conference call the same day beginning at approximately noon Eastern Time by...

TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) — AGF Management Limited reported total fee-earning assets under management (AUM) of $38.8 billion as at November 30, 2019. 

BURLINGTON, Mass., Dec. 05, 2019 (GLOBE NEWSWIRE) — The Avid Customer Association (ACA), in collaboration with Avid® (Nasdaq: AVID), today announced that registration has opened for Avid Connect 2020, the powerful annual gathering of media and entertainment technology users and influencers. Avid Connect 2020 “Collective Vision” presents an exciting opportunity for attendees to collaborate and problem-solve with peers, learn from and inspire others, and gain a fresh perspective to advance their organizations and careers. The conference will be held April 17-18, 2020 at Wynn Las Vegas immediately preceding the NAB Show. Register for Avid Connect 2020 at www.avid.com/connect. Avid Connect 2020 will feature more customer-led sessions and workshops for creatives and technologists working in the media and entertainment industry. Peers...

VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) — Nevada Exploration Inc. (“NGE” or the “Company”) (TSX-V: NGE; OTCQB: NVDEF) is pleased to announce that it has closed its previously announced non-brokered private placement offering (the “Offering”), pursuant to which it has issued 5,625,000 units (the “Units”) at a price of $0.20 CAD per Unit, for gross proceeds of $1,125,000 CAD.Commenting on the financing, NGE’s President, James Buskard: “As we shared in our South Grass Valley Project update news release last month, based on continued positive results, we’ve planned an ambitious follow-up drilling program for 2020.  With this financing now complete, we’re in discussions with contractors, and subject to availability, our goal is to restart drilling next month.  Our team is excited to get back out drilling, and we sincerely...

SEATTLE, Dec. 05, 2019 (GLOBE NEWSWIRE) — Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, today announced that Kyle Guse, CFO, will be a featured presenter at the LD Micro Main Event on December 10, 2019 at 12:40 pm PST, at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.Management will also be available for one-on-one meetings. In addition, the corporate presentation will be available on Atossa’s website at https://www.atossagenetics.com/investors/.For those interested in attending or for registered attendees who wish to request meetings, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.About Atossa GeneticsAtossa Genetics Inc. is a clinical-stage...

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) — via NetworkNewsAudio –  Sigma Labs Inc. (NASDAQ: SGLB) announces the availability of a broadcast titled, “Unleashing the Disruptive Forces of 3D Printing.”To hear the NetworkNewsWire Audio version, visit:  http://nnw.fm/1T7jmTo read the full editorial, visit: http://nnw.fm/g3zStPrintRite3D 5.1 uniquely leverages thermal signatures to monitor the quality of each product part in the production process, layer by layer and in real time. This allows operators to correct or stop production of a defective part, resulting in reduced error rates and higher yields. This incredibly sophisticated and powerful technology may hold enormous potential value.To date, Sigma Labs Inc. (NASDAQ: SGLB) has engaged 19 beta customers, including many of the biggest names in the industry, with more evaluation programs...

MELBOURNE, Australia, Dec. 05, 2019 (GLOBE NEWSWIRE) — Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), announced today that it has received positive efficacy data from preclinical studies of its Cymerus™ mesenchymal stem cells (MSCs) in a model of sepsis.  Sepsis, sometimes referred to as blood poisoning, is a life-threatening condition that arises from the body’s response to an infection or injury.Key HighlightsIn a preclinical model of severe pneumonia-induced sepsis, Cymerus MSC treatment:° Increased blood oxygen levels° Increased lung compliance (the ability of lungs to stretch and expand)° Decreased alveolar neutrophil infiltration (which can lead to lung injury)° Decreased barrier permeability (which allows harmful proteins into the lungs)° Decreased inflammationThe extent of...

TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) — African Gold Group, Inc. (TSX-V: AGG) (“AGG” or the “Company”) will be hosting a conference call today at 10:00 am EST today to provide an update to its shareholders.About African Gold GroupAfrican Gold Group is a Canadian listed exploration and development company on the TSX Venture Exchange (TSX-V: AGG) with its focus on developing a gold platform in West Africa. Its principal asset is the Kobada Project in southern Mali. For more information regarding African Gold Group visit our website at www.africangoldgroup.com.For further information please contact:Stan BhartiPresident and Chief Executive Officer(416) 861 2267Forward-Looking StatementsThis press release contains “forward looking information” within the meaning of applicable Canadian securities legislation. Forward looking...

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver liquidity to the global markets and provide execution services and data, analytics and connectivity products, announced today that Virtu CEO, Douglas A. Cifu will present at the Goldman Sachs U.S. Financial Services Conference on Wednesday, December 11, 2019 at 2:40 p.m. ET. The event will be available live and in replay via webcast on the investor relations section of Virtu’s website at http://ir.virtu.com/.About Virtu Financial, Inc.:Virtu is a leading provider of financial services and products that leverages cutting-edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. Leveraging...